Evidence map›Paper›PMID 32359161›Full record

ArticleMolecular human reproduction2020

Use of a human embryonic stem cell model to discover GABRP, WFDC2, VTCN1 and ACTC1 as markers of early first trimester human trophoblast.

Rowan M Karvas, Samuel McInturf, Jie Zhou, Toshihiko Ezashi, Danny J Schust, R Michael Roberts, Laura C Schulz

Open access · greenAbstract read
In one paragraph

Article in Molecular human reproduction, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Effects of oxycodone on placental lineages: Evidence from the transcriptome profile of mouse trophoblast giant cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Bioengineering-tissue strategies to model mammalian implantationFrontiers in bioengineering and biotechnology · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rowan M KarvasDivision of Biological Sciences, University of Missouri, Columbia, MO 65211, USA.
Samuel McInturfDivision of Plant Sciences, University of Missouri, Columbia, MO 65211, USA.
Jie ZhouDepartment of Obstetrics, Gynecology, and Women's Health, University of Missouri, Columbia, MO 65212, USA.
Toshihiko EzashiDivision of Animal Sciences, University of Missouri, Columbia, MO 65211, USA.
Danny J SchustDepartment of Obstetrics, Gynecology, and Women's Health, University of Missouri, Columbia, MO 65212, USA.
R Michael RobertsDivision of Animal Sciences, University of Missouri, Columbia, MO 65211, USA.
Laura C SchulzDivision of Biological Sciences, University of Missouri, Columbia, MO 65211, USA.
University of Missouri · USUniversity of Missouri Health System · US

Funding

Modeling Normal and Abnormal TrophoblastsR01HD094937 · NICHD · UNIVERSITY OF MISSOURI-COLUMBIA · PI R. MICHAEL ROBERTS, Laura Clamon SCHULZ · 2018 to 2026
$4.5M
Pluripotent human stem cells as models for normal and diseased trophoblastR01HD067759 · NICHD · UNIVERSITY OF MISSOURI-COLUMBIA · PI ROBERTS, R. MICHAEL · 2011 to 2015
$1.7M
NICHD NIH HHS R01 HD067759NICHD NIH HHS R01 HD094937
6 · The paper itself

Abstract

Human placental development during early pregnancy is poorly understood. Many conceptuses are lost at this stage. It is thought that preeclampsia, intrauterine growth restriction and other placental syndromes that manifest later in pregnancy may originate early in placentation. Thus, there is a need for models of early human placental development. Treating human embryonic stem cells (hESCs) with BMP4 (bone morphogenic protein 4) plus A83-01 (ACTIVIN/NODAL signaling inhibitor) and PD173074 (fibroblast growth factor 2 or FGF2 signaling inhibitor) (BAP conditions) induces differentiation to the trophoblast lineage (hESCBAP), but it is not clear which stage of trophoblast differentiation these cells resemble. Here, comparison of the hESCBAP transcriptome to those of trophoblasts from human blastocysts, trophoblast stem cells and placentas collected in the first-third trimester of pregnancy by principal component analysis suggests that hESC after 8 days BAP treatment most resemble first trimester syncytiotrophoblasts. To further test this hypothesis, transcripts were identified that are expressed in hESCBAP but not in cultures of trophoblasts isolated from term placentas. Proteins encoded by four genes, GABRP (gamma-aminobutyric acid type A receptor subunit Pi), WFDC2 (WAP four-disulfide core domain 2), VTCN1 (V-set domain containing T-cell activation inhibitor 1) and ACTC1 (actin alpha cardiac muscle 1), immunolocalized to placentas at 4-9 weeks gestation, and their expression declined with gestational age (R2 = 0.61-0.83). None are present at term. Expression was largely localized to syncytiotrophoblast of both hESCBAP cells and placental material from early pregnancy. WFDC2, VTCN1 and ACTC1 have not previously been described in placenta. These results support the hypothesis that hESCBAP represent human trophoblast analogous to that of early first trimester and are a tool for discovery of factors important to this stage of placentation.

Indexed as

ActinsEmbryonic Stem CellsHuman Embryonic Stem CellsHumansImmunohistochemistryPrincipal Component AnalysisReceptors, GABA-ATranscriptomeTrophoblastsV-Set Domain-Containing T-Cell Activation Inhibitor 1WAP Four-Disulfide Core Domain Protein 2ACTC1 protein, humanActinsGABRP protein, humanReceptors, GABA-AV-Set Domain-Containing T-Cell Activation Inhibitor 1VTCN1 protein, humanWAP Four-Disulfide Core Domain Protein 2embryonic stem cellshuman blastocyst implantationplacental developmentprimitive syncytiumtrophoblast differentiation

Identifiers

PMID32359161
PMCPMC7320820
OpenAlexW3022905671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.